Equine Healthcare Market Size To Reach $5.91 Billion By 2030

Equine Healthcare Market Growth & Trends

The global equine healthcare market size is expected to reach USD 5.91 billion by 2030, registering a CAGR of 8.32% during the forecast period, according to a new report by Grand View Research, Inc. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses. 

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8^th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

 Request a free sample copy or view report summary: Equine Healthcare Market Report

Equine Healthcare Market Report Highlights

• Based on product, the pharmaceuticals segment dominated the market with a share of over 25.96% in 2023 owing to a high uptake and wide availability of these products

• The others product segment comprising regenerative medicine and stem cell therapy solutions is projected to be the fastest growing segment in the forecast period

• Based on indication, parasite infections segment held the largest share of over 26.56% in 2023. It is due to the growing demand for effective parasiticides for the control of internal and external parasites

• The sports/racing activity segment dominated the market with a revenue share of over 56.38% in 2023 and is anticipated to grow at the fastest rate during the forecast period

• Based on distribution channel, veterinary hospitals and clinics held the largest share in 2023. The e-commerce segment is projected to expand at the fastest CAGR during the forecast period

• North America and Europe held notable shares in 2023. The Asia Pacific is expected to witness lucrative growth in the forecast period owing to a budding equine racing/ sports sector.

Equine Healthcare Market Segmentation

Grand View Research has segmented the global equine healthcare market based on product, indication, activity, distribution channel & region:

Equine Healthcare Product Type Outlook (Revenue, USD Million, 2018 - 2030)

• Vaccines

• Pharmaceuticals

  • Parasiticides

  • Anti-infectives

  • Anti-inflammatory & Analgesics

  • Other Pharmaceuticals

• Medicinal Feed Additives

• Orthobiologics

• Diagnostics

  • Diagnostic Test Kits

  • Diagnostic Equipment

• Software & Services

  • Practice Management Software

  • Imaging Software

  • Telehealth Software

  • Other Software

• Other Products

Equine Healthcare Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Musculoskeletal Disorders

• Parasitic Infections

• Equine Herpes Virus

• Equine Viral Arteritis (EVA)

• Equine Influenza

• West Nile Virus

• Tetanus

• Other Indications

Equine Healthcare Activity Outlook (Revenue, USD Million, 2018 - 2030)

• Sports/Racing

• Recreation

• Other Activities

Equine Healthcare Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Veterinary Hospitals & Clinics

• E-commerce

• Equestrian Facilities

• Other Channels

Equine Healthcare Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Netherlands

  • Russia

  • Switzerland

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Equine Healthcare Market

• Zoetis

• Arthrex Inc.

• Dechra Pharmaceuticals

• Boehringer Ingelheim International GmbH

• Ceva Sante Animale

• Heska Corporation

• Merck & Co. Inc

• Esaote SPA

• IDEXX Laboratories, Inc.

• Covetrus Inc.

• Elanco

• Cargill